IGFBP2 and glioblastoma: GBM cells release a spectrum of proteins, including insulin-like growth factor-binding protein 2 (IGFBP2), myeloid-derived growth factors, and metalloproteinase inhibitor 2, which act as signaling mediators in the microenvironment [154].